Clinical Trials Logo

Filter by:
NCT ID: NCT01901107 Completed - Clinical trials for Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Start date: January 2013
Phase: N/A
Study type: Observational

The purpose of this survey is to evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

NCT ID: NCT01900665 Terminated - Alzheimer's Disease Clinical Trials

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

EXPEDITION 3
Start date: July 2013
Phase: Phase 3
Study type: Interventional

To test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.

NCT ID: NCT01900054 Completed - Clinical trials for Perennial Allergic Rhinitis

A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Start date: June 2013
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the long-term safety and efficacy of TAU-284 (Bepotastine besilate) in pediatric patients with perennial allergic rhinitis for 12 weeks administration.

NCT ID: NCT01898845 Completed - Clinical trials for Advanced Solid Tumors

A Phase I Study of LEE011 in Asian Patients

Start date: May 2013
Phase: Phase 1
Study type: Interventional

This study will evaluate safety and tolerability to estimate the MTD and/or recommended dose for expansion.

NCT ID: NCT01898780 Enrolling by invitation - Clinical trials for Patients Who Undergo Pancreatoduodenectomy

Horizontal Mattress vs. Interrupted Suture in Surgical Techniques of Pancreaticojejunostomy

Start date: June 2013
Phase: Phase 3
Study type: Interventional

The aim of this study is to verify that the frequency of pancreatic fistula (ISGPF grade B and C) in horizontal mattress suture are lower than in interrupted suture during pancreaticojejunostomy in pancreatoduodenectomy by randomized clinical trial.

NCT ID: NCT01898624 Completed - Overactive Bladder Clinical Trials

Specified Drug Use-results Survey of Betanis Tablets

Start date: December 4, 2012
Phase: N/A
Study type: Observational

To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.

NCT ID: NCT01897558 Completed - Bradyarrhythmia Clinical Trials

Myocardial Micro-damage in Relation to Active and Passive Fixation Pacemaker Electrodes

PACMAN
Start date: April 2013
Phase: N/A
Study type: Interventional

Pacemaker electrodes are either equipped with tines (passive fixation) or with a screw (active fixation) for initial fixation in the patient´s heart. Both types of electrodes provide similar results in a long-term follow-up and the use of one or the other electrode type in many instances is mainly based on the implanter´s preference. The PACMAN-trial investigates whether the two lead types are associated with different amounts of myocardial micro-damage during implantation.

NCT ID: NCT01897532 Completed - Clinical trials for Diabetes Mellitus, Type 2

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Start date: July 10, 2013
Phase: Phase 4
Study type: Interventional

The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with Type 2 diabetes mellitus (T2DM) and to compare outcomes against placebo, on a background of standard of care.

NCT ID: NCT01896830 Completed - Clinical trials for Clostridium Difficile Infection

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan

Start date: July 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of the study is to evaluate a candidate C. difficile Toxoid Vaccine in the Japanese population. Primary objectives: - To describe the safety profile of all subjects who receive at least 1 injection - To describe the immunogenicity to toxin A and toxin B in all subjects from serum samples obtained on Days 0, 14, 30, and 60.

NCT ID: NCT01896388 Completed - Clinical trials for Posttraumatic Stress Disorders

Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial

Start date: January 21, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Accumulating evidence suggests a key role of the N-methyl-D-aspartate (NMDA) receptor in the pathophysiology of post-traumatic stress disorder (PTSD). Recent studies suggest that the NMDA receptor antagonist ifenprodil tartrate may be a potential therapeutic drug for PTSD. The purpose of this study is to confirm whether ifenprodil tartrate is effective in the treatment of adolescents PTSD patients. If ifenprodil tartrate is effective in these patients, this study contributes to the development of novel therapeutic drugs for PTSD.